Skip to content

Abnormal B Cell Morphology C4021748

Published: July 22, 2026Updated: August 20, 2026

Structural abnormalities in B cells, which are immune cells that produce antibodies to fight infection. Can affect individuals with certain immune disorders. Management involves monitoring and treating underlying conditions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Neurological symptoms

Headaches, confusion, numbness, or vision changes that may indicate central nervous system involvement or compression.

Seek immediate emergency care for sudden severe headache, vision changes, seizures, or altered consciousness.

!

Shortness of breath

Difficulty breathing or breathlessness, which may indicate severe anemia, cardiac involvement, or pleural effusion.

Seek immediate care for sudden or worsening shortness of breath, chest pain, or difficulty breathing at rest.

Persistent fatigue

(constitutional)

Overwhelming tiredness and lack of energy that does not improve with rest, often due to anemia or the underlying disease process affecting blood cell production.

Frequency: 70-80% of patients

Unexplained fever

(constitutional)

Recurrent fevers without obvious infection source, resulting from immune system dysregulation and abnormal B-cell function.

Frequency: 60-70% of patients

Easy bruising or bleeding

(hematologic)

Increased tendency to bruise easily or experience bleeding from gums, nose, or minor cuts due to low platelet count or platelet dysfunction.

Frequency: 40-50% of patients

Swollen lymph nodes

(lymphatic)

Enlarged lymph nodes, typically in neck, armpits, or groin, resulting from abnormal B-cell proliferation or immune response.

Frequency: 50-60% of patients

Recurrent infections

(immunologic)

Frequent bacterial, viral, or fungal infections due to impaired B-cell function and abnormal antibody production.

Frequency: 40-50% of patients

Skin rash or lesions

(dermatologic)

Various skin manifestations including itchy rash, papules, or nodules, often related to autoimmune complications or cutaneous involvement.

Frequency: 20-30% of patients

Bone pain

(musculoskeletal)

Deep bone or joint pain, often in the back, hips, or long bones, caused by bone marrow involvement or abnormal cell infiltration.

Frequency: 15-25% of patients

Abdominal pain or fullness

(gastrointestinal)

Persistent abdominal discomfort, pain, or feeling of fullness due to enlarged spleen or abdominal lymph nodes.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular immunological surveillance

Periodic measurement of B-cell counts, immunoglobulins, and lymphocyte subsets helps monitor disease progression and guide treatment decisions.

monitoring

Additional treatment options

Immunoglobulin replacement therapy

IV or subcutaneous immunoglobulin replacement provides passive immunity when endogenous B-cell function is insufficient, reducing infection frequency and severity.

medication

Prophylactic antibiotics

Continuous or intermittent prophylactic antibiotics such as trimethoprim-sulfamethoxazole may reduce bacterial infections in patients with significant B-cell deficiency.

medication

Immune support with micronutrient optimization

Supplementation with zinc, selenium, vitamin D, and other immunomodulatory nutrients may support overall immune function in patients with B-cell abnormalities.

complementary

Nutritional support with protein adequacy

Ensuring adequate protein intake and balanced nutrition supports immune cell production and function, particularly important when B-cell production is impaired.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal B Cell Morphology C4021748?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC), Lyon, France.

guideline2022View source →
2

Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Edition.

review2017View source →
3

American Society of Hematology. Clinical Practice Guidelines: B-cell Lymphomas.

guideline2021View source →
4

Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th Edition. Elsevier.

review2020
5

Hoffbrand AV, Pettit JE, Vyas P. Color Atlas of Clinical Hematology. 5th Edition. Wiley-Blackwell.

textbook2019
6

Kluin PM, Burger J, Tousseyn T. WHO classification of lymphoid neoplasms: the increasingly complex story.

position_statement2022View source →
7

Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

consensus2019View source →
8

Jaffe ES, Arber DA, Campo E, et al. Hematopathology: Expert Consult - Online and Print. 2nd Edition. Elsevier.

review2018
9

Thieblemont C, Zucca E. Clinical aspects and therapy of marginal zone lymphoma.

clinical_trial2020View source →
10

Porwit A, McCullough J, Erber WN. Blood and Bone Marrow Pathology. 2nd Edition. Elsevier.

other2018

Medication Comparisons

Compare medications used to treat Abnormal B Cell Morphology C4021748. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy